AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 OCT 9 - (NewsRx.com & NewsRx.net) -- Vical, Inc., (VICL) announced the expansion of its management team with the appointment of Alain P. Rolland, PharmD, PhD, as vice president, product development, and the appointment of Thomas G. Evans, MD, as executive director, infectious diseases clinical research.
Vical's chief scientific officer, David C. Kaslow, MD, said, "As part of expanding Vical's independent in-house product development effort, we have successfully recruited two more accomplished development experts. Alain's preclinical product development expertise from a decade of industry experience in gene therapy and DNA-based gene delivery is a perfect fit for directing Vical's preclinical testing and development programs. Tom's experiences in clinical infectious diseases, in immunology basic research, and in conducting clinical trials of investigational vaccines, most recently HIV DNA vaccines, is consistent with our goal of ...
Source: HighBeam Research, 'Naked DNA Company' expands management team.(Brief Article)